Clinical effectiveness and safety of once-weekly glp-1 receptor agonist dulaglutide as add-on to metformin or metformin plus insulin secretagogues in obesity and type 2 diabetes

RAUL MIGUEL LUQUE HUERTAS2026-01-292026-01-29202110.3390/jcm100509852-s2.0-85107514750https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/33504Medicine (all)Clinical effectiveness and safety of once-weekly glp-1 receptor agonist dulaglutide as add-on to metformin or metformin plus insulin secretagogues in obesity and type 2 diabetesresearch article